Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis

OBJECTIVE: Treatments for enthesitis-related arthritis (ERA) consist of a mono- or combination therapy with non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs (DMARDs), and biological agents, and they are primarily based on adult studies and studies on other forms of juven...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Rheumatol
Hlavní autoři: Kısaarslan, Ayşenur Paç, Sözeri, Betül, Gündüz, Zübeyde, Zararsız, Gökmen, Poyrazoğlu, Hakan, Düşünsel, Ruhan
Médium: Artigo
Jazyk:Inglês
Vydáno: Medical Research and Education Association 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668635/
https://ncbi.nlm.nih.gov/pubmed/31070580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2019.18180
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky